The metabolic effects of antipsychotic drugs
Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, may explain why some antipsychotic drugs can promote overeating, weight gain, and insulin resistance.
Olanzapine, an atypical antipsychotic drug approved by the FDA for the treatment of schizophrenia and bipolar disorder, has been associated with body weight gain and impaired glucose homeostasis in humans and in experimental animals. As part of a Dutch research consortium, studies led by Simon Evers (University of Groningen, the Netherlands) sought to reveal underlying mechanisms for olanzapine’s metabolic effects by studying healthy adult male volunteers. The research was motivated by observations of what co-author Anton Scheurink described as “a mysterious interaction between schizophrenia and diabetes.”
Their results confirmed previous findings that olanzapine induces weight gain by increasing caloric intake, but also revealed that olanzapine reduces body temperature, which contributes to decreased energy expenditure. Indeed, reduced body temperature after olanzapine treatment may generate many of the known side effects of this antipsychotic drug. The authors’ new findings also demonstrate that olanzapine alters peripheral glucose metabolism, which may contribute to impaired insulin sensitivity. According to lead author Simon Evers, “Our research group believes that reduced body temperature is the foremost direct and consistent effect of olanzapine in humans and in experimental animals. Reduced body temperature might explain several of olanzapine’s metabolic side effects, including increased food intake, reduced energy expenditure, sedation, high blood sugar, body weight gain, and insulin resistance.”
Research supported by Top Institute Pharma: (T2-105).
Lead author: S. Evers (University of Groningen, The Netherlands)
Co-authors: A.J.W. Scheurink, G. van Dijk (University of Groningen, Groningen, Netherlands), and A. van Vliet (PRA International, Zuidlaren, Netherlands)
Contact Authors: Simon S. Evers, M.Sc., and Anton J.W. Scheurink, PhD.
Email: s.s.evers@rug.nl a.j.w.scheurink@rug.nl
Phone: +31650874021 +31628999689
Press Contacts:
Jamie Price
Society for the Study of Ingestive Behavior
admin@ssib.org
(312) 238-9068
Media Contact
More Information:
http://www.ssib.orgAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
Microscopic basis of a new form of quantum magnetism
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…
NASA selects UF mission to better track the Earth’s water and ice
NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…
